Salud financiera de hoja de balance de Cannara Biotech
Salud financiera controles de criterios 3/6
Cannara Biotech tiene un patrimonio de accionistas total de CA$81.8M y una deuda total de CA$48.2M, lo que sitúa su ratio deuda-patrimonio en 58.9%. Sus activos y pasivos totales son CA$148.8M y CA$67.0M respectivamente. El BAIT de Cannara Biotech es de CA$8.6M, por lo que su ratio de cobertura de intereses es de 1.8. Tiene efectivo e inversiones a corto plazo que ascienden a CA$5.5M.
Información clave
58.9%
Ratio deuda-patrimonio
CA$48.17m
Deuda
| Ratio de cobertura de intereses | 1.8x |
| Efectivo | CA$5.46m |
| Patrimonio | CA$81.77m |
| Total pasivo | CA$67.00m |
| Activos totales | CA$148.77m |
Actualizaciones recientes sobre salud financiera
These 4 Measures Indicate That Cannara Biotech (CVE:LOVE) Is Using Debt Extensively
Oct 29
Does Cannara Biotech (CVE:LOVE) Have A Healthy Balance Sheet?
Jul 14Is Cannara Biotech (CVE:LOVE) A Risky Investment?
Jul 29Here's Why Cannara Biotech (CVE:LOVE) Has A Meaningful Debt Burden
Jan 26Cannara Biotech (CVE:LOVE) Has A Somewhat Strained Balance Sheet
Dec 10Here's Why Cannara Biotech (CSE:LOVE) Can Afford Some Debt
Mar 16Recent updates
These 4 Measures Indicate That Cannara Biotech (CVE:LOVE) Is Using Debt Extensively
Oct 29Cannara Biotech Inc.'s (CVE:LOVE) 33% Price Boost Is Out Of Tune With Earnings
Aug 22Cannara Biotech (CVE:LOVE) Shareholders Will Want The ROCE Trajectory To Continue
Aug 21Does Cannara Biotech (CVE:LOVE) Have A Healthy Balance Sheet?
Jul 14Cannara Biotech Inc.'s (CVE:LOVE) Prospects Need A Boost To Lift Shares
May 09Here's Why We Think Cannara Biotech (CVE:LOVE) Might Deserve Your Attention Today
Feb 28Investor Optimism Abounds Cannara Biotech Inc. (CVE:LOVE) But Growth Is Lacking
Jan 24Cannara Biotech's (CVE:LOVE) Earnings May Just Be The Starting Point
Dec 18Is Cannara Biotech (CVE:LOVE) A Risky Investment?
Jul 29Cannara Biotech Inc.'s (CVE:LOVE) Business Is Yet to Catch Up With Its Share Price
Apr 10Here's Why Cannara Biotech (CVE:LOVE) Has A Meaningful Debt Burden
Jan 26Cannara Biotech's (CVE:LOVE) Earnings Aren't As Good As They Appear
Jan 27Cannara Biotech (CVE:LOVE) Has A Somewhat Strained Balance Sheet
Dec 10Here's Why Cannara Biotech (CSE:LOVE) Can Afford Some Debt
Mar 16Can You Imagine How Cannara Biotech's (CSE:LOVE) Shareholders Feel About The -6.5% Share Price Increase?
Jan 22
Have Insiders Been Buying Cannara Biotech Inc. (CSE:LOVE) Shares?
Dec 18Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (CA$62.0M) de LOVE superan a sus pasivos a corto plazo (CA$26.8M).
Pasivo a largo plazo: Los activos a corto plazo de LOVE (CA$62.0M) superan a sus pasivos a largo plazo (CA$40.2M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: La relación deuda neta-capital de LOVE (52.2%) se considera alta.
Reducción de la deuda: El ratio deuda-patrimonio de LOVE ha crecido de 30.5% a 58.9% en los últimos 5 años.
Cobertura de la deuda: La deuda de LOVE está bien cubierta por el flujo de caja operativo (20.6%).
Cobertura de intereses: Los pagos de intereses de la deuda de LOVE no están bien cubiertos por el BAIT (1.8x cobertura).